GlassScriptPhysician profile
Terry D Sims
NPI 1598948333
$2,098.70
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,099.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $515.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $312.78 | 2021 | |
| Novo Nordisk INC | $190.65 | 2021 | |
| Esperion Therapeutics, INC. | $175.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $119.99 | 2021 | |
| Amgen INC. | $91.26 | 2021 | |
| Amarin Pharma, INC. | $90.76 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $71.29 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $56.50 | 2021 | |
| Pfizer INC. | $55.43 | 2021 | |
| Eisai INC. | $51.52 | 2021 | |
| Merck Sharp & Dohme LLC | $43.39 | 2021 | |
| Glaxosmithkline, LLC. | $31.43 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $29.04 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.52 | 2021 | |
| Astellas Pharma US INC | $19.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.51 | 2021 | |
| Gilead Sciences, INC. | $15.55 | 2021 | |
| Currax Pharmaceuticals LLC | $14.38 | 2021 | |
| Insulet Corporation | $13.02 | 2021 | |
| Endo Pharmaceuticals INC. | $12.00 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.